Sunday, February 8, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

S&P 500 Retreats from Record High as Fed Pivot Unnerves Investors

Felix Baarz by Felix Baarz
September 18, 2025
in Analysis, Market Commentary, S&P 500
0
S&P 500 Stock
0
SHARES
140
VIEWS
Share on FacebookShare on Twitter

The S&P 500 concluded a choppy trading session with modest losses after briefly touching a new intraday record. The benchmark index reached a high of 6,619 points before a wave of profit-taking pushed it down to close at 6,600.35, a decline of 6.41 points from its previous close of 6,606.76. Investor caution prevailed following the first interest rate cut by the U.S. Federal Reserve since December.

Fed’s Policy Shift and Market Reaction

In a widely anticipated but nonetheless pivotal move, the Federal Open Market Committee (FOMC) reduced the federal funds rate to a target range of 4.00% to 4.25%. While the 25-basis-point cut was fully priced in by markets, the central bank’s ambiguous forward guidance on the path of future rate reductions created uncertainty. The CBOE Volatility Index (VIX), a key gauge of market fear, closed at 16.36, indicating a noticeable uptick in trader anxiety.

Notable Stock Movers: Leaders and Laggards

Individual stock performances were a major focal point of the session, with significant gains and losses driven by company-specific news.

Top Performers:
* Hologic (HOLX) surged 7.7% on reports of acquisition interest from private equity firms Blackstone and TPG.
* Workday (WDAY) advanced 7.3% after activist investor Elliott Investment Management disclosed a multi-billion dollar stake in the company.
* Lyft (LYFT) boomed 13% higher following the announcement of a new strategic partnership with Waymo to deploy autonomous ride-hailing vehicles.

Key Decliners:
* Nvidia (NVDA) slid 2.7% amid reports of new Chinese restrictions on chip purchases by its domestic tech firms.
* Uber (UBER) dropped 5%, a direct negative reaction to its rival Lyft’s favorable autonomous driving news.
* Home improvement stocks felt pressure from a softening housing outlook, with Builders FirstSource (BLDR) falling 5.6% and Mohawk Industries (MHK) declining 4%.

Sector performance was mixed. Technology and consumer cyclical stocks emerged as areas of weakness, while more defensive sectors such as Healthcare demonstrated relative stability.

Should investors sell immediately? Or is it worth buying S&P 500?

Technical Picture Maintains Bullish Bias

From a technical analysis perspective, the S&P 500 continues to trade within a well-defined upward trend that has been in place since April. The index is consolidating above the psychologically important 6,600 level and remains comfortably above its 50-day moving average, which resides in the 6,400-6,407 point range.

  • Key Resistance Levels: 6,650, 6,648, and 6,803 points
  • Key Support Levels: 6,508, 6,480, and 6,500 points

Broader market breadth continues to show underlying positive momentum, reinforcing the bullish foundational support for the index.

Market Outlook Hinges on Federal Reserve Policy

The market’s near-term trajectory is expected to be heavily influenced by the Federal Reserve’s communication and its updated economic projections. The Fed’s suggestion of two additional rate cuts in 2025 remains a central focus for investors.

In related markets, the yield on the 10-year U.S. Treasury note hovered around the 4% threshold, while the U.S. Dollar Index (DXY) stabilized at 96.95. Commodities presented a mixed picture, with oil trading around $64 per barrel and gold pulling back from its recent record highs to trade below $3,700.

Concerns over a potential slowdown in job growth coupled with persistent inflationary pressures continue to dominate the macroeconomic narrative. A key question is whether corporate share buybacks, which fell 20.1% in the second quarter, can stage a recovery in the current quarter. The answer to this will likely play a significant role in the market’s next major directional move.

Ad

S&P 500 Stock: Buy or Sell?! New S&P 500 Analysis from February 8 delivers the answer:

The latest S&P 500 figures speak for themselves: Urgent action needed for S&P 500 investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 8.

S&P 500: Buy or sell? Read more here...

Tags: S&P 500
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

Quanterix Stock
Analysis

Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test

February 8, 2026
Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

February 7, 2026
Repay Holdings Stock
Analysis

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Next Post
Marsh McLennan Stock

Marsh McLennan Shares Present a Market Conundrum

Polestar Auto.adr/a Stock

Polestar's Financial Crossroads: Surging Sales Amid Deepening Losses

Delta Air Lines Stock

US Regulatory Blow and Mixed Outlook Challenge Delta Air Lines

Recommended

Biotechnology Stock Exchange

Analysts Bullish on Dynatrace with Price Targets on the Rise

2 years ago
The Trade Desk Stock

The Trade Desk Faces Mounting Pressure as Amazon Strikes Netflix Deal

5 months ago

Analyst Reaffirms Buy Rating on International Seaways with 66 Price Target

2 years ago
Biotechnology Stock Bull Market

KeyBanc Analyst Raises Price Target and Maintains Overweight Rating on Repligen NASDAQ RGEN

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

Repay Holdings: Annual Report to Test Strategic Refinancing Success

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Trending

Puma Biotechnology Stock
Earnings

Puma Biotechnology Sets Date for Full-Year Financial Disclosure

by Jackson Burston
February 8, 2026
0

Investor attention is now firmly fixed on February 26, 2026, as Puma Biotechnology prepares to release its...

Quanterix Stock

Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test

February 8, 2026
Design Therapeutics Stock

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

February 7, 2026
Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Puma Biotechnology Sets Date for Full-Year Financial Disclosure
  • Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test
  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com